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Abstract
Background: This study conducted in Northeastern Brazil, evaluated the prevalence of H. pylori infection and the
presence of gastritis in HIV-infected patients.
Methods: There were included 113 HIV-positive and 141 age-matched HIV-negative patients, who underwent upper
gastrointestinal endoscopy for dyspeptic symptoms. H. pylori status was evaluated by urease test and histology.
Results: The prevalence of H. pylori infection was significantly lower (p < 0.001) in HIV-infected (37.2%) than in
uninfected (75.2%) patients. There were no significant differences between H. pylori status and gender, age, HIV
viral load, antiretroviral therapy and the use of antibiotics. A lower prevalence of H. pylori was observed among
patients with T CD4 cell count below 200/mm
3; however, it was not significant. Chronic active antral gastritis was
observed in 87.6% of the HIV-infected patients and in 780.4% of the control group (p = 0.11). H. pylori infection
was significantly associated with chronic active gastritis in the antrum in both groups, but it was not associated
with corpus chronic active gastritis in the HIV-infected patients.
Conclusion: We demonstrated that the prevalence of H. pylori was significantly lower in HIV-positive patients
compared with HIV-negative ones. However, corpus gastritis was frequently observed in the HIV-positive patients,
pointing to different mechanisms than H. pylori infection in the genesis of the lesion.
Background
Helicobacter pylori infection is the major etiologic factor of
chronic gastritis and peptic ulcer in the general popula-
tion. Gastrointestinal (GI) symptoms are frequent among
patients infected with human immunodeficiency virus
(HIV) and with acquired immunodeficiency syndrome
(AIDS) [1,2] However, the role of H. pylori infection in the
GI tract mucosa of HIV patients is not well defined [3].
Some studies suggested that interactions between the
immune/inflammatory response, gastric physiology and
host repair mechanisms play an important role in dictating
the disease outcome in response to H. pylori infection,
suggesting that the host’s immune competence might be
an important issue in H. pylori infection [4,5].
Data in regard to the prevalence of H. pylori infection
in HIV-infected population are controversial. Some
reports have shown that the rate of the infection in
HIV-positive patients is remarkably low when compared
with the general population [6,7]. Conversely, other stu-
dies have not found similar results [8-10].
It is well known that the immune deficiencies caused
by HIV give rise to many different gastrointestinal oppor-
tunistic infections, such as cytomegalovirus (CMV) infec-
tion and fungal esophagitis [11,12]. However, there are
few studies evaluating the gastric mucosa of patients co-
infected by H. pylori and HIV [13-15].
Therefore, the aim of this study was to evaluate the
prevalence of H. pylori infection, risk factors associated
with the infection, as well as the macroscopic and
microscopic alterations of the gastric mucosa of HIV-
infected patients in a high H. pylori prevalence area in
Northeastern, Brazil.
Methods
The study was approved by the Ethical Committee of
Research of the University of Ceará, and informed con-
sent was obtained from each patient. This prospective
cross-sectional study was carried out at the Hospital
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HIV-infected individuals in the city of Fortaleza, Ceará,
Brazil. From May 2001 to April 2003, 113 HIV-positive
patients who underwent upper gastrointestinal endo-
s c o p yf o rd y s p e p t i cs y m p t o m sw e r ei n c l u d e di nt h e
study. The control group was composed by 141
HIV-negative patients who were undergoing upper gas-
trointestinal endoscopy for investigation of dyspeptic
symptoms at the University Hospital Walter Cantideo,
Fortaleza, Ceara, Brazil. Patients and age matched con-
trols (interval of 10 years) were enrolled at the same
period. All patients gave written informed consent to
participate in the study and answered a questionnaire
about symptoms and consumption of medications,
including acid secretion inhibitors and antibiotics six
months before endoscopy. In t h eH I V - p o s i t i v ep a t i e n t
group, data regarding the risk factors for HIV infection
and antiretroviral therapy were also obtained. Total
T CD4 cell count and HIV viral load were accepted as
v a l i di ft h eb l o o ds a m p l ef o rtheir determination had
been taken within 1 month before or after the entrance
in the study.
Upper gastrointestinal endoscopy
Gastro-endoscopy was performed with Olympus video
endoscopes (Olympus Optical Co, Ltd. GIF TYPE V) in
the standard manner. Fragments of the gastric mucosa
were obtained from the five sites recommended by the
Houston-updated Sydney system for classification of
gastritis and to evaluate the presence of spiral microor-
ganism stained by Giemsa [16]. Two fragments from the
lesser curvature of the gastric antrum and two from the
lesser curvature of the lower gastric body were obtained
for urease test. The activity of chronic gastritis was
classified as mild, moderate and marked based on the
number of neutrophil infiltration. The specimens were
fixed in 10% formalin, embedded in paraffin wax, and
5-mm sections were stained with hematoxylin and eosin
for histology and with Giemsa staining to evaluate
H. pylori status.
Exclusion criteria included age below 18 years old or
above 80 years old, other serious medical problems, or
previous treatment for H. pylori infection. H. pylori
status was determined by the rapid urease test and his-
tology (Giemsa staining) and was considered negative
when both tests were negative.
Statistical Analysis
Data were analyzed using the software SPSS (version 10.0,
Chicago, IL). Chi square test with Yates’ correction or
Fischer’s exact test were used to compare results among
the different groups. Significance was accepted at P values
below 0.05.
Results
Two hundred and fifty four subjects were included: 113
HIV-infected patients and 141 age-matched controls. The
mean age of HIV infected patients was 36.0 years (range,
21-70 years) and 61.9% (70/113) were male. The mean age
of the control group was 39.7 years (range 18-76 years)
and 36.2% (51/141) were male. Most of the symptoms of
HIV-positive patients were nonspecific, such as diarrhea,
dyspepsia, abdominal pain, nausea, vomiting, odynophagia
or dysphagia. The frequency of diarrhea, odynophagia, and
dysphagia was significantly higher in HIV-positive group
compared with the controls (P < 0.05).
Macroscopic lesions in the HIV-infected group
included, widespread esophageal candidiasis (32.7%;
37/113), esophageal ulcers (7.9%; 9/113) and candidiasis
plus esophageal ulcers (1.7%; 2/113). Cryptosporidium
was found in the gastric mucosa of two HIV-infected
patients. Table 1 shows the endoscopic gastric mucosal
findings in HIV-positive and HIV-negative dyspeptic
patients. Corpus gastritis was significantly more fre-
quently observed in the dyspeptic HIV-positive than in
HIV-negative patients.
The overall prevalence of H. pylori infection was sig-
nificantly lower (p < 0.001) in HIV-infected patients
(37.2%; 42/113) when compared with the controls
(75.2%; 106/141); and did not increase with age (p =
0.73). Of note, the infection prevalence in the oldest
group did not differ between HIV-positive and HIV-
negative patients. The prevalence of H. pylori infection
in the HIV-positive patients and controls according to
the age is shown in Figure 1.
In the HIV-positive group,t h e r ew a sn os i g n i f i c a n t
difference between H. pylori status and gender, age, HIV
viral load, antiretroviral therapy and the use of antibio-
tics and H2-blocker. Only 4 patients referred the use of
proton pump inhibitors (PPI). A non-significant lower
prevalence of H. pylori infection was observed in the
patients with T CD4 cell count below 200 (Table 2).
Table 1 Endoscopic findings of the gastroduodenal
mucosa of dyspeptic HIV-positive and negative patients
Endoscopic
findings
HIV + (n = 113 HIV - (n = 141) Total p-value
N (%) N (%) N
Normal 0 (18.0) 30 (22.0) 50 0.57
Antral gastritis 44 (38.9) 41 (29.1) 85 0.10
Corpus Gastritis 42 (37.2) 25 (12.1) 67 <0.001
Pangastritis 3 (2.7) 0 3 0.05
Gastric erosion 16 (14.2) 27 (19.2) 43 0.29
Gastric ulcer 2 (1.7) 3 (2.1) 5 0.83
Duodenitis 5 (4.4) 2 (1.4) 7 0.15
Duodenal erosion 3 (2.7) 2 (1.4) 5 0.84
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Table 3. Chronic active antral gastritis was observed
in 87.6% (99/113) of the HIV-infected patients and
in 80.1% (113/141; p = 0.11) of the control group.
H. pylori infection was significantly associated with the
presence of chronic active antral gastritis in both
groups (p = 0.03 and p < 0.001, respectively). No sig-
nificant difference (p = 0.89) was also observed
between the groups in respect to the frequency of
chronic active corpus gastritis (53.1% in the HIV-posi-
tive patients and 53.9% in the HIV-negative patient).
However, the H. pylori infection did not associate with
chronic active corpus gastritis in the HIV-positive
patients (p = 0.15), but high association was observed
in the HIV-negative ones (p < 0.001). Additionally, in
the HIV-negative group, the degree of gastritis was
also associated with H. pylori infection, being the pre-
sence of the microorganism more frequently observed
in the more marked (50%, 40/80) than in moderated
(10%, 2/20) gastritis. Atrophy/intestinal metaplasia was
observed less frequently in the gastric corpus of HIV-
positive (6.2%, 7/113) than in the gastric corpus of
HIV-negative (9.9%, 14/141) patients, but the differ-
ences were not significant (p = 0.27).
Discussion
T h ep r e v a l e n c eo fH. pylori infection was lower in the
HIV-positive group than in the age-matched controls.
The low prevalence of H. pylori infection we observed
in the HIV-positive patients differs profoundly from that
previously reported (82.0%) in HIV-negative adults from
ap o o ru r b a nC o m m u n i t yi nt h es a m ec i t y( F o r t a l e z a ;
Brazil) [17]. A similar result has been observed in a
cross-sectional study in Southeastern Brazil that evalu-
ated the prevalence of H. pylori infection in 528 HIV-
infected patients (32.38% of H. pylori positivity) [18].
Studies from East countries, where H. pylori infection is
highly prevalent such as Taiwan [19] and China [20]
also demonstrated a lower H. pylori infection prevalence
(17.3% and 22.1%, respectively) in HIV-infected than in-
non-infected (63.5% and 44.8%, respectively) patients.
Conversely, studies from Argentina and from India
showed similar H. pylori infection prevalence in HIV-
infected and non infected patients [13,21,22].
It has to be emphasized that H. pylori infection was
diagnosed by histology and urease test in all patients.
The results were concordant with those obtained by the
evaluation of H. pylori specific ureA gene in the paraffin
imbedded gastric tissue from a subgroup of patients
(data not shown) and both HIV-positive and -negative
patients belong to the same low-income population. As
above mentioned, the prevalence of H. pylori infection
in a similar population from Fortaleza in respect to the
socio-economical level is high [17]. It is well known that
H. pylori infection is mainly acquired during childhood
and that once acquired it is life-long lasting [1]. There-
fore, we may hypothesize that the HIV-infected patients
we studied had been exposed to the bacterium early in
life and most of them became infected, but loose the
infection after acquired HIV infection. Alternatively,
the H. pylori gastric load might be decreased in the
HIV-positive patients leading to H. pylori infection mis-
diagnosis. Explanations include decreased gastric acid
secretion predisposing to gastric colonization by other
microorganisms that might compete with H. pylori,t h e
use of either antibiotics or PPI and, as suggested in
other studies, the low count of T CD4 cells in AIDS
patients [6,21,23,24].
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Figure 1 Helicobacter pylori infection in HIV-positive and
-negative patients according to the age.
Table 2 Covariates associated with H. pylori infection in
HIV-positive patients
Variables H. pylori + N (%) Total p-value
Gender
Female 17 (39.5) 43 0.68
Male 25 (35.7) 70
CD4 count
≤200 17 (28.8) 59 0.06
>200 25 (46.3) 54
Viral load
<100.10
3 30 (42.8) 71 0.11
≥100. 10
3 12 (27.9) 42
Antibiotics
No 23 (44.2) 52 0.15
Yes 19 (31.1) 61
Use of H2-blocker
No 31 (38.3) 76 0.25
Yes 11 (16.6) 37
Antifungic therapy
No 36 (40.5) 87 0.09
Yes 6 (29.7) 26
Antiretroviral therapy HAART
No 12 (38.3) 42 0.15
Yes 30 (16.6) 71
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inducing or perpetuating tissue and epithelial damage
that may facilitate H. pylori colonization [25]. In this
study, HIV-positive patients were stratified according to
the T CD4 cell counts above or below 200 cells/mm3
and a tendency of lower prevalence of H. pylori infec-
tion was observed in the group of patients with T CD4
cell count of 200 or below.
Hypochlorhydria has been described in HIV-positive
patients [23]. Previous studies have shown that HIV-
positive patients with overt AIDS have significantly
increased serum levels of gastrin and pepsinogen II
compared with HIV-positive patients without overt
AIDS [26]. Hypochlorhydria may provide a less suitable
environment for H. pylori and predispose to overgrowth
of other bacteria [27]. Inhibition of H. pylori by compe-
tition with other opportunistic pathogens such as Cyto-
megalovirus via unknown mechanisms has been also
suggested [23,28]. The intragastric environment may be
also modified by previous use of PPI. In this study; how-
ever, only four HIV-positive patients were under PPI
therapy. The frequent usage of antibiotics for treatment
or prophylaxis against opportunistic infections in
patients at an advanced stage of HIV infection might
explain the low prevalence of H. pylori i n f e c t i o ni nt h e
patient group. However, the antibiotics most commonly
used in AIDS patients are not always efficacious against
H. pylori. Furthermore, low H. pylori eradication ratio is
observed with the use of mono therapy, even with clari-
thromycin that has a good anti-H. pylori activity [29].
An interesting finding observed in this study was the
presence of active chronic gastritis in the gastric body of
HIV-positive patients independently of the H. pylori posi-
tivity, in agreement with the studies of Welage et al.;
Marano et al., and Mach et al. [23,30,31], which; however,
was not observed by others [6,32]. Otherwise, in this
study, the H. pylori status was significantly associated
with the presence of active chronic gastritis in the antral
g a s t r i cm u c o s ao fH I V - p o s i t i v ea n d- n e g a t i v ep a t i e n t s .
Taking together the data, it is possible that different
mechanisms participate in the development of corpus
chronic active gastritis in HIV-positive patients. There-
fore, other microorganisms such as Cytomegalovirus or
some drugs used to treat AIDS and to prevent opportu-
nistic infections may play a role [18,33].
Conclusion
Although the prevalence of H. pylori infection in HIV-
positive patients was lower than in HIV-negative ones,
the presence of chronic active gastritis was similarly
high either in HIV-positive or -negative patients, which
points to the possibility that other mechanisms than
H. pylori infection are involved in the genesis of corpus
gastritis in HIV positive patients.
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